IGF1R and pancreatic neoplasm: In pancreatic cancer cell lines such as PANC-1 and HPAC, downregulation of IGF-1R not only impairs proliferative and metastatic signaling through the MAPK and JAK/STAT pathways but also reduces EMT and insulin receptor β expression [90].